At 5pm, the activists lit candles on the front lawns in the shape of “GAZA” and held a vigil to commemorate the lost lives in the genocide.
Author: Zeina Khochaiche
Welcome to the sixth instalment of Honi Soit’s student media spotlight — a series where we sit down with student publications around Australia to discuss the triumphs and tribulations of student media.
On Tuesday, April 23, University of Sydney student and staff activists commenced their first day of a campout in support of encampments at Columbia University and other US campuses.
There was so much work to even sign up for the app that downloading it felt like a feverish farce. I was curious if I made it onto the app, would I even see any “celebrities”, and could I even hold my own as a “non-celebrity.”
The March meeting’s agenda included the ‘circular resolution policy’, ‘new clubs application appeal’, USU approval items, finance reports, a refresher of USyd’s Strategic Plan, and the executive reports.
Like most universities, UOW has a student newspaper. Unlike most universities, its paper The Tertangala is older than the university itself.
You may have noticed construction fences and “don’t enter” signs littered around campus. Or maybe you’re hearing rumblings of building demolitions? From Cadigal green to Manning house, it is clear the University is implementing several construction projects. What are they? How long will they take? And which parts impact you? Let’s talk about it.
In an open letter, civil rights organisations have called for the government to repeal “anti-democratic” NSW anti-protest laws, or failing that, introduce “a community consultation component into the statutory review of the 2022 amendments.”
Meta’s unwillingness to return to the negotiation table places media platforms of all kinds in a vulnerable position as Australia awaits their fate — a fate held in inexorable and indifferent hands.
Generic versions of essential ADHD medications like Adderall, Vyvanse and Concerta remain in varying degrees of shortage across the globe. It has been an international pharmaceutical issue since August of last year and has only worsened since.